Trial Profile
EFFECT OF MARAVIROC ON THE TRANSCRIPTION OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) IN RESTING CD4+ T LYMPHOCYTES IN PATIENTS ON ANTIRETROVIRAL TREATMENT WITH SUPPRESSED VIRAL LOAD EFECTO DEL MARAVIROC SOBRE LA TRANSCRIPCIÓN DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA (VIH-1) EN LINFOCITOS T CD4+ EN REPOSO EN PERSONAS CON CARGA VIRAL SUPRIMIDA POR TRATAMIENTO ANTIRRETROVIRAL
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MARAVITRANS
- 11 Dec 2012 New trial record